RATIONALE O
: O
NG B
- I
nitro I
- I
L I
- I
arginine I
( O
L B
- I
NOARG I
) O
, O
an O
inhibitor O
of O
nitric B
- I
oxide I
synthase O
( O
NOS O
) O
, O
induces O
catalepsy O
in O
mice O
. O

These O
effects O
were O
completely O
antagonized O
by O
pretreatment O
with O
a O
glutamate B
/ O
N B
- I
methyl I
- I
D I
- I
aspartate I
antagonist O
, O
aminophosphonovaleric B
acid I
. O

Ultrastructural O
damage O
and O
levels O
of O
4 B
- I
hydroxy I
- I
2 I
- I
nonenal I
( O
4HNE B
) O
- O
protein O
adducts O
and O
3 B
- I
nitrotyrosine I
( O
3NT B
) O
were O
analyzed O
. O

5 B
- I
Fluorouracil I
cardiotoxicity O
induced O
by O
alpha B
- I
fluoro I
- I
beta I
- I
alanine I
. O

We O
herein O
report O
the O
case O
of O
a O
70 O
- O
year O
- O
old O
man O
with O
5 B
- I
FU I
- O
induced O
cardiotoxicity O
, O
in O
whom O
a O
high O
serum O
level O
of O
alpha B
- I
fluoro I
- I
beta I
- I
alanine I
( O
FBAL B
) O
was O
observed O
. O

We O
hypothesized O
that O
increased O
venous O
smooth O
muscle O
( O
venomotor O
) O
tone O
plays O
a O
role O
in O
Nomega B
- I
nitro I
- I
L I
- I
arginine I
( O
LNNA B
) O
hypertension O
through O
these O
mechanisms O
. O

OBJECTIVES O
: O
The O
risk O
of O
acute O
myocardial O
infarction O
( O
AMI O
) O
with O
COX B
- I
2 I
inhibitors I
may O
offset O
their O
gastrointestinal O
( O
GI O
) O
benefit O
compared O
with O
non O
- O
selective O
( O
NS O
) O
non B
- I
steroidal I
anti I
- I
inflammatory I
drugs I
( O
NSAIDs O
) O
. O

In O
these O
HPMA B
copolymers O
, O
DOX B
was O
covalently O
bound O
via O
peptide O
linkages O
that O
were O
either O
non O
- O
biodegradable O
( O
Gly O
- O
Gly O
) O
or O
degradable O
by O
lysosomal O
proteinases O
( O
Gly B
- I
Phe I
- I
Leu I
- I
Gly I
) O
. O

Myo B
- I
inositol I
- I
1 I
- I
phosphate I
( O
MIP B
) O
synthase O
inhibition O
: O
in O
- O
vivo O
study O
in O
rats O
. O

EEG O
undertaken O
during O
inpatient O
stay O
showed O
changes O
consistent O
with O
encephalopathy O
, O
and O
low O
titre O
N B
- I
methyl I
- I
D I
- I
aspartate I
( O
NMDA B
) O
receptor O
antibodies O
were O
present O
in O
this O
patient O
. O

In O
this O
study O
, O
we O
investigated O
the O
effects O
of O
Re B
, I
Rg1 I
, I
and I
Rb1 I
ginsenosides I
, O
the O
bioactive O
components O
of O
ginseng O
, O
on O
OIH O
. O

MK B
- I
801 I
, O
a O
noncompetitive O
N B
- I
methyl I
- I
D I
- I
aspartate I
( O
NMDA B
) O
receptor O
antagonist O
, O
was O
tested O
for O
anticonvulsant O
effects O
in O
rats O
using O
two O
seizure O
models O
, O
coadministration O
of O
lithium B
and O
pilocarpine B
and O
administration O
of O
a O
high O
dose O
of O
pilocarpine B
alone O
. O

The O
effects O
of O
oral O
administration O
of O
caffeine B
( O
10 O
mg O
/ O
kg O
) O
on O
behavioral O
ratings O
, O
somatic O
symptoms O
, O
blood O
pressure O
and O
plasma O
levels O
of O
3 B
- I
methoxy I
- I
4 I
- I
hydroxyphenethyleneglycol I
( O
MHPG B
) O
and O
cortisol B
were O
determined O
in O
17 O
healthy O
subjects O
and O
21 O
patients O
meeting O
DSM O
- O
III O
criteria O
for O
agoraphobia O
with O
panic O
attacks O
or O
panic O
disorder O
. O

The O
role O
of O
p B
- I
aminophenol I
in O
acetaminophen B
- O
induced O
nephrotoxicity O
: O
effect O
of O
bis B
( I
p I
- I
nitrophenyl I
) I
phosphate I
on O
acetaminophen B
and O
p B
- I
aminophenol I
nephrotoxicity O
and O
metabolism O
in O
Fischer O
344 O
rats O
. O

Therefore O
, O
the O
effect O
of O
bis B
( I
p I
- I
nitrophenyl I
) I
phosphate I
( O
BNPP B
) O
, O
an O
acylamidase O
inhibitor O
, O
on O
APAP B
and O
PAP B
nephrotoxicity O
and O
metabolism O
was O
determined O
. O

Although O
moderate O
anticonvulsant O
effects O
of O
S B
- I
312 I
- I
d I
in O
higher O
doses O
were O
observed O
against O
the O
clonic O
convulsions O
induced O
by O
pentylenetetrazole B
( O
85 O
mg O
/ O
kg O
, O
s O
. O
c O
. O
) O
or O
bemegride B
( O
40 O
mg O
/ O
kg O
, O
s O
. O
c O
. O
) O
, O
no O
effects O
were O
observed O
in O
convulsions O
induced O
by O
N B
- I
methyl I
- I
D I
- I
aspartate I
, O
picrotoxin B
, O
or O
electroshock O
in O
Slc O
: O
ddY O
mice O
. O

Milk O
- O
alkali O
syndrome O
induced O
by O
1 B
, I
25 I
( I
OH I
) I
2D I
in O
a O
patient O
with O
hypoparathyroidism O
. O

